CAR-T Cell Complications

Skip to main content

Narrative Reviews

CAR-T Cell Therapy Complications

Image: Shutterstock / Schira

Major Haematological Trials | Major Haematological Guidelines

Sections

General | Monitoring & Investigations | Therapies

General

General

Schroeder. Management of chimeric antigen receptor T (CAR-T) cell-associated toxicities. Intensive Care Med 2024;epublished August 22nd
Bellal. Toxicities, intensive care management, and outcome of chimeric antigen receptor T cells in adults: an update. Crit Care 2024;28(1):69
Asghar. Toxicities of CAR T-cell therapy: a review of current literature. Ann Med Surg 2023;85(12):6013–6020
Rejeski. Recognizing, defining, and managing CAR-T hematologic toxicities. Hematol Am Soc Hematol Educ Program 2023;2023(1):198-208

Background

Pathophysiology

Conditions

Sepsis

García-Poutón. Post-CART-T Cell Infection: Etiology, pathogenesis, and therapeutic approaches. Rev Esp Quimioter 2023; 36 (Suppl. 1): 52-53.

Complications

Complication

Monitoring & Investigations

General

Therapies

General